Company Filing History:
4 out of 987 
2 out of 441 
1 out of 29 Years Active: 2006-2025
Title: Yoshiaki Taniyama: Innovator in Pharmaceutical Composition
Introduction
Yoshiaki Taniyama is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases associated with periostin expression. With a total of 5 patents to his name, Taniyama's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
One of Taniyama's latest patents is a pharmaceutical composition designed for the treatment of diseases associated with upregulated periostin expression or periostin splice variant switching. This composition includes a nucleic acid capable of inducing skipping of exon 17 and/or exon 21 in periostin gene transcription. This innovative approach aims to treat diseases while preserving the essential functions of periostin. Another notable patent involves an antibody against a peptide encoded by Exon-21 of periostin, which is intended for preventing or treating inflammation-associated diseases. This drug targets a periostin isoform that has cell adhesion activity, providing a new avenue for therapeutic intervention.
Career Highlights
Taniyama has worked with esteemed institutions such as Osaka University and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Throughout his career, Taniyama has collaborated with notable colleagues, including Ryuichi Morishita and Naruto Katsuragi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yoshiaki Taniyama's contributions to pharmaceutical innovation highlight his commitment to addressing complex medical issues through inventive solutions. His work continues to impact the field positively, paving the way for future advancements in treatment options.